Acadia Healthcare (ACHC) Cut to “Hold” at BidaskClub

Share on StockTwits

BidaskClub lowered shares of Acadia Healthcare (NASDAQ:ACHC) from a buy rating to a hold rating in a report issued on Thursday morning.

A number of other analysts have also issued reports on the company. ValuEngine lowered Acadia Healthcare from a sell rating to a strong sell rating in a research report on Thursday, September 6th. Mizuho set a $37.00 target price on Acadia Healthcare and gave the company a hold rating in a research report on Tuesday, August 28th. BMO Capital Markets lowered Acadia Healthcare from an outperform rating to a market perform rating and set a $45.00 target price on the stock. in a research report on Wednesday, August 1st. Jefferies Financial Group boosted their target price on Acadia Healthcare from $44.00 to $47.00 and gave the company a buy rating in a research report on Tuesday, July 31st. Finally, Credit Suisse Group boosted their target price on Acadia Healthcare from $40.00 to $44.00 and gave the company a neutral rating in a research report on Tuesday, July 31st. One analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have given a buy rating to the company’s stock. The stock presently has an average rating of Buy and an average price target of $44.36.

ACHC stock opened at $35.95 on Thursday. The company has a market cap of $3.24 billion, a PE ratio of 15.24, a PEG ratio of 1.32 and a beta of 0.62. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.24 and a current ratio of 1.24. Acadia Healthcare has a one year low of $26.92 and a one year high of $49.05.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Monday, July 30th. The company reported $0.70 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.70. The company had revenue of $765.70 million for the quarter, compared to analyst estimates of $767.93 million. Acadia Healthcare had a return on equity of 7.93% and a net margin of 7.52%. The firm’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.66 earnings per share. analysts forecast that Acadia Healthcare will post 2.52 earnings per share for the current year.

In other Acadia Healthcare news, Director Reeve B. Waud sold 8,135 shares of the business’s stock in a transaction on Thursday, July 26th. The shares were sold at an average price of $45.00, for a total value of $366,075.00. Following the completion of the transaction, the director now owns 14,213 shares in the company, valued at $639,585. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 11.10% of the company’s stock.

Several large investors have recently bought and sold shares of ACHC. Dimensional Fund Advisors LP grew its stake in shares of Acadia Healthcare by 41.3% in the first quarter. Dimensional Fund Advisors LP now owns 4,031,525 shares of the company’s stock worth $157,955,000 after acquiring an additional 1,178,151 shares in the last quarter. Rothschild Asset Management Inc. acquired a new position in shares of Acadia Healthcare in the first quarter worth $30,903,000. Copper Rock Capital Partners LLC acquired a new position in shares of Acadia Healthcare in the second quarter worth $27,394,000. Aristotle Capital Management LLC grew its stake in shares of Acadia Healthcare by 7.4% in the first quarter. Aristotle Capital Management LLC now owns 6,638,790 shares of the company’s stock worth $260,108,000 after acquiring an additional 454,924 shares in the last quarter. Finally, P2 Capital Partners LLC grew its stake in shares of Acadia Healthcare by 14.5% in the first quarter. P2 Capital Partners LLC now owns 3,350,000 shares of the company’s stock worth $131,253,000 after acquiring an additional 425,000 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.

Featured Article: Short Selling

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply